Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of Mar 03, 2025, Hims & Hers Health, Inc.'s discount rate is 9.03%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Hims & Hers Health, Inc.'s capital structure and risk profile.
Hims & Hers Health, Inc.'s WACC as of Mar 03, 2025, is 9.03%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.
Hims & Hers Health, Inc.'s cost of equity is 9.0%, as of Mar 03, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.